UK based, Aptamer Group, and Hong Kong headquartered, BaseCure Therapeutics, are paring up on the development of ...
Amgen is launching Amjevita, or adalimumab-atto, a biosimilar to AbbVie’s Humira, in the US; it is the first such biosimilar ...
An agreement between the two countries means they can use each other’s good manufacturing practice inspections of ...
The unprecedented rise in approvals for new cell and gene therapies, and the increasing industry need for cell lines to ...
The candidate reported efficacy of 83.7% against RSV-associated lower respiratory tract disease: with Moderna set to file for ...
Biotech company, Vaxxas, has secured a partnership agreement with the Coalition for Epidemic Preparedness Innovations CEPI) ...
Janssen’s experimental HIV vaccine regimen was found to be safe but ineffective in the Phase 3 Mosaico clinical trial: and as ...
Evotec has entered into a strategic collaboration and licence agreement with Janssen Biotech: with the partnership focusing ...
The European Commission (EC) has expanded the marketing authorization for Regeneron and Sanofi’s Dupixent (dupilumab) in the ...
Phase 3 data for efanesoctocog alfa has been published in the New England Journal of Medicine (NEJM): ahead of a decision on ...
Novartis subsidiary, Sandoz, has secured a postive option from an EMA commitee in relation to its high concentration and ...
US senators, Elizabeth Warren and Peter Welch, are urging Moderna to reconsider the proposed price increases for its COVID-19 ...